EcoDrugPlus

Neurogenic Locus Notch Homolog Protein 1

Ensembl ID : ENSMZEG00005014036
Gene Symbol: LOC101473768
3 Cross references
201 Possible Orthologues:

Neurogenic Locus Notch Homolog Protein 2

Ensembl ID : ENSMZEG00005018681
Gene Symbol: LOC101484507
3 Cross references
197 Possible Orthologues:

Neuromedin-K Receptor

Ensembl ID : ENSMZEG00005019910
Gene Symbol: LOC101480479
3 Cross references
218 Possible Orthologues:

Neuronal Acetylcholine Receptor Subunit Alpha-2-Like

Ensembl ID : ENSMZEG00005021625
Gene Symbol: LOC101486300
3 Cross references
193 Possible Orthologues:

Neuronal Acetylcholine Receptor Subunit Alpha-7

Ensembl ID : ENSMZEG00005013435
Gene Symbol: LOC101471490
3 Cross references
205 Possible Orthologues:

Neuronal Acetylcholine Receptor Subunit Alpha-7

Ensembl ID : ENSMZEG00005000663
Gene Symbol: LOC101470212
2 Cross references
183 Possible Orthologues:

Neuropeptide Y Receptor Y2

Ensembl ID : ENSMZEG00005007073
Gene Symbol: NPY2R
1 Cross references
184 Possible Orthologues:

Neuropeptide Y Receptor Y4-2

Ensembl ID : ENSMZEG00005004403
Gene Symbol: NPY4R2
1 Cross references
116 Possible Orthologues:

Neuropeptide Y Receptor Type 2

Ensembl ID : ENSMZEG00005027846
Gene Symbol: LOC101468176
3 Cross references
176 Possible Orthologues:

Neurotensin Receptor 1

Ensembl ID : ENSMZEG00005025679
Gene Symbol: NTSR1
1 Cross references
203 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 1

Ensembl ID : ENSMZEG00005016495
Gene Symbol: NTRK1
3 Cross references
199 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 2

Ensembl ID : ENSMZEG00005009643
Gene Symbol: NTRK2
4 Cross references
204 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).